Related references
Note: Only part of the references are listed.Myoadenylate deaminase deficiency: clinico-pathological and molecular study of a series of 27 Spanish cases
S. Teijeira et al.
CLINICAL NEUROPATHOLOGY (2011)
Molecular Mechanism by Which AMP-Activated Protein Kinase Activation Promotes Glycogen Accumulation in Muscle
Roger W. Hunter et al.
DIABETES (2011)
Re-evaluating the general(ized) roles of AMPK in cellular metabolism
Julie Mantovani et al.
FEBS LETTERS (2011)
Suppression of 5′-Nucleotidase Enzymes Promotes AMP-activated Protein Kinase (AMPK) Phosphorylation and Metabolism in Human and Mouse Skeletal Muscle
Sameer S. Kulkarni et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Structure of mammalian AMPK and its regulation by ADP
Bing Xiao et al.
NATURE (2011)
AMPK Is a Direct Adenylate Charge-Regulated Protein Kinase
Jonathan S. Oakhill et al.
SCIENCE (2011)
Defining the Molecular Nexus of Cancer, Type 2 Diabetes and Cardiovascular Disease
S. M. Cabarcas et al.
CURRENT MOLECULAR MEDICINE (2010)
Downregulation of AMPK Accompanies Leucine- and Glucose-Induced Increases in Protein Synthesis and Insulin Resistance in Rat Skeletal Muscle
Asish K. Saha et al.
DIABETES (2010)
Metformin: Taking away the candy for cancer?
Mathilde Jalving et al.
EUROPEAN JOURNAL OF CANCER (2010)
Additive effect of contraction and insulin on glucose uptake and glycogen synthase in muscle with different glycogen contents
Yu-Chiang Lai et al.
JOURNAL OF APPLIED PHYSIOLOGY (2010)
AMPK and the biochemistry of exercise: implications for human health and disease
Erik A. Richter et al.
BIOCHEMICAL JOURNAL (2009)
AMPK in Health and Disease
Gregory R. Steinberg et al.
PHYSIOLOGICAL REVIEWS (2009)
Activation of glucose transport and AMP-activated protein kinase during muscle contraction in adenylate kinase-1 knockout mice
S. -J. Zhang et al.
ACTA PHYSIOLOGICA (2008)
Thienopyridone Drugs Are Selective Activators of AMP-Activated Protein Kinase β1-Containing Complexes
John W. Scott et al.
CHEMISTRY & BIOLOGY (2008)
Structural basis for AMP binding to mammalian AMP-activated protein kinase
Bing Xiao et al.
NATURE (2007)
Investigating the mechanism for AMP activation of the AMP-activated protein kinase cascade
Matthew J. Sanders et al.
BIOCHEMICAL JOURNAL (2007)
Activation of AMP-activated protein kinase in the liver: a new strategy for the management of metabolic hepatic disorders
Benoit Viollet et al.
JOURNAL OF PHYSIOLOGY-LONDON (2006)
Insulin antagonizes ischemia-induced Thr172 phosphorylation of AMP-activated protein kinase α-subunits in heart via hierarchical phosphorylation of Ser485/491
S Horman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Contraction-mediated phosphorylation of AMPK is lower in skeletal muscle of adenylate kinase-deficient mice
CR Hancock et al.
JOURNAL OF APPLIED PHYSIOLOGY (2006)
Chutes and ladders: The search for protein kinases that act on AMPK
LA Witters et al.
TRENDS IN BIOCHEMICAL SCIENCES (2006)
AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolism
BB Kahn et al.
CELL METABOLISM (2005)
Mammalian 5′-nucleotidases
V Bianchi et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
N-terminal extensions of the human AMPD2 polypeptide influence ATP regulation of isoform L
AL Haas et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
The relationship between AMP-activated protein kinase activity and AMP concentration in the isolated perfused rat heart
M Frederich et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Quantitative analysis of inward and outward transport rates in cells stably expressing the cloned human serotonin transporter: Inconsistencies with the hypothesis of facilitated exchange diffusion
HH Sitte et al.
MOLECULAR PHARMACOLOGY (2001)
Human cytosolic 5′-nucleotidase I -: Characterization and role in nucleoside analog resistance
SA Hunsucker et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia
AS Marsin et al.
CURRENT BIOLOGY (2000)
Metabolism and cytotoxic effects of 2-chloroadenine, the major catabolite of 2-chloro-2′-deoxyadenosine
F Bontemps et al.
BIOCHEMICAL PHARMACOLOGY (2000)
Share Paper
